2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
Open accessThe DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee (https://doi.org/10.2337/dc20-SPPC), a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Type 2 diabetes is characterized by insulin resistance driven by chronic hyperglycemia”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Self-citation(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Diagnosis and Classification of diabetes mellitus
(2014) · Diapedia · doi:10.14496/dia..20 · Cited by 3,214
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Research works printed but not linked: 2
- Dabelea, 2014, SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for Diabetes in Youth Study, e938
- Araneta, 2014, Optimum BMI cut-points to screen Asian Americans for type 2 diabetes: The UCSD Filipino Health Study and the North Kohala Study [Abstract], A20
Cited by
Items 901–1,000 of 1,010
Liu, T., Fan, Z., Xiao, B., Chang, H., & Wang, S. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02200-7 · Cited by 16
“…Cardiology guidelines for the diagnosis and management of patients with STEMI [14], while diagnosis of NSTEMI and UA were based on 2016 Guidelines and consensus for the management of patients with non-ST-elevation ACS [15]; and (3) T2D patients diagnosed based on ADA guidelines (2020 edition) [16].”
MethodLiu, H., Zhang, L., Cheng, H., Chi, P., Zhuang, Y., Alifu, X., Zhou, H., Qiu, Y., Huang, Y., Ainiwan, D., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1396347 · Cited by 18
Scisciola, L., Rizzo, M. R., Marfella, R., Cataldo, V., Fontanella, R. A., Boccalone, E., Paolisso, G., & Barbieri, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30185 · Cited by 16
Liu, L., Ma, X., Xu, H., Ruan, S., & Yuan, X. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.003 · Cited by 18
D’Alessandra, Y., Chiesa, M., Vigorelli, V., Ricci, V., Rurali, E., Raucci, A., Colombo, G. I., Pompilio, G., & Vinci, M. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031423 · Cited by 16
Eberle, C., & Stichling, S. (2021) · JMIR Diabetes · doi:10.2196/20270 · Cited by 17
Baek, J. Y., Lim, D. H., Oh, D., Nam, H., Kim, J. J., Lee, J. H., Min, B., & Lee, H. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2021.073 · Cited by 16
Dai, S., Hong, H., Zhou, K., Zhao, K., Xie, Y., Li, C., Shi, J., Zhou, Z., Nie, L., & Wu, Z. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00032 · Cited by 16
Du, R., & Li, L. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s310866 · Cited by 17
Yao, J., Fan, S., Shi, X., Gong, X., Zhao, J. W., & Fan, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253492 · Cited by 20
Farkas, G. J., Gordon, P., Trewick, N., Gorgey, A. S., Dolbow, D. R., Tiozzo, E., Berg, A. S., & Gater, D. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235591 · Cited by 20
Hashemi, S. J., Karandish, M., Cheraghian, B., & Azhdari, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00990-z · Cited by 19
Zhang, H., Tian, W., & Sun, Y. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03087-3 · Cited by 16
Kim, S.-K., Oh, H.-J., Oh, S., & Koh, S. B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127550 · Cited by 19
Zin, C. A. J. C. M., Mohamed, W. M. I. W., Khan, N. A. K., & Ishak, W. R. W. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.3.257 · Cited by 20
“The contrasting findings contributed to bioavailability, variety, ripeness, culinary technique, storage, region, and environmental conditions (Castro-Barquero et al., 2020).”
BackgroundAntidiabetic properties of mango in animal models and humans: A systematic review
Zarasvand, S. A., Mullins, A. P., Arjmandi, B. H., & Haley‐Zitlin, V. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.01.003 · Cited by 18
Qin, Y.-N., & Zheng, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01165-z · Cited by 16
“Diabetes was defined as a self-reported diabetes diagnosis, use of diabetes medications or insulin, HbA1c ≥ 6.5%, fasting plasma glucose level ≥ 7.0 mmol/L, or random blood glucose (mmol/l) ≥ 11.1 mmol/L, 2-h OGTT blood glucose (mmol) ≥ 11.1 [18].”
MethodInfluentialMODY2 in Asia: analysis of GCK mutations and clinical characteristics
Zhou, Y., Wang, S., Wu, J., Dong, J., & Liao, L. (2020) · Endocrine Connections · doi:10.1530/ec-20-0074 · Cited by 17
Xu, J.-H., Lo, Y.-M. M., Chang, W.-C., Huang, D.-W., Wu, J. S., Jhang, Y.-Y., Huang, W., Ko, C., & Shen, S. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6644253 · Cited by 20
“Once the body presents hyperglycemia and hyperinsulinemia, it can be prone to many complications [1].”
Diels, S., Cuypers, B., Tvarijonaviciute, A., Derudas, B., Dijck, E. V., Verrijken, A., Gaal, L. F. V., Laukens, K., Lefèbvre, P., Cerón, J. M. C., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01142-1 · Cited by 18
Leite, M. M., Dutra, M. T., da Costa, M. V. G., Funghetto, S. S., Silva, A. D. O., de Lima, L. R., da Silva, I. C. R., Mota, M. R., & Stival, M. M. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111389 · Cited by 15
Cai, S.-S., Zheng, T.-Y., Wang, K.-Y., & Zhu, H.-P. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i1.43 · Cited by 15
DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling
Zhou, H., Mu, X., Hu, H., Zhao, S., Hu, N., Yang, M., & Jiang, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530823 · Cited by 15
Diabetes Detection and Prevention in Dermatology
Ngo, A., Froessl, L. J., McWhorter, J. W., Perkison, W. B., & Katta, R. (2021) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1104a131 · Cited by 16
Lupusoru, G. E., Ailincăi, I., Sorohan, B. M., Andronesi, A. G., Achim, C. A., Micu, G., Caragheorgheopol, A., Manda, D. A., Lupușoru, M. O. D., & Ismail, G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109116 · Cited by 17
Yacamán-Méndez, D., Zhou, M., Lagerros, Y. T., Gómez‐Velasco, D., Tynelius, P., Guðjónsdóttir, H., de Leon, A. P., Eeg‐Olofsson, K., Östenson, C., Brynedal, B., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02551-6 · Cited by 18
Yue, C., Zhang, C., Ying, C., & Jiang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.993785 · Cited by 18
Chen, G., Tan, C., Liu, X., Wang, X., Tan, Q., & Chen, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030756 · Cited by 15
Khalfallah, M., Elnagar, B., Soliman, S., Eissa, A., & Allaithy, A. M. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220606 · Cited by 19
Wang, L., Wang, C., Liu, T., Xuan, H., Li, X., Shi, X., Dai, F., Chen, J., Li, D., & Xu, T. (2023) · Archives of Public Health · doi:10.1186/s13690-023-01148-6 · Cited by 18
“Diabetes was defined as the self-reported history of diabetes, fasting plasma glucose ≥ 126 mg/dL, hemoglobin A1c ≥ 6.5%, or taking medications to lower blood sugar [20].”
BackgroundInfluentialHuhn, E. A., Göbl, C. S., Fischer, T., Bernasconi, M. T., Kreft, M., Kunze, M., Vogt, D., Dölzlmüller, E., Jaksch‐Bogensperger, H., Heldstab, S. A., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2022-000330 · Cited by 15
Suri, P., Arora, A., Kinra, K., & Arora, V. (2023) · Indian Journal of Clinical Cardiology · doi:10.1177/26324636231199029 · Cited by 15
Kamel, A. M., Ismail, B., Hafiz, G. A., Sabry, N. A., & Farid, S. F. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0164 · Cited by 15
Vitamin D3 improves glucose metabolism and attenuates inflammation in prediabetic human and mice
Zhang, Y., Ni, P., Miao, Y., Chen, H., Tang, L., Song, H., Li, W., & Li, X. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109659 · Cited by 16
Surgical management of the diabetic foot: The current evidence
Roberts, R. H. R., Davies-Jones, G., Brock, J., Satheesh, V., & Robertson, G. A. J. (2024) · World Journal of Orthopedics · doi:10.5312/wjo.v15.i5.404 · Cited by 17
Jensen, E. T., Bertoni, A. G., Crago, O. L., Hoffman, K. L., Wood, A. C., Arzumanyan, Z., Lam, L. K., Roll, K., Sandow, K., Wu, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14145 · Cited by 15
Chen, C., Liu, X., Liu, L., Lo, K. K.-H., Yu, Y., Huang, J., Huang, Y., & Chen, J. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s272624 · Cited by 15
Hommos, N. A. A., Ebenibo, S., Edeoga, C., & Dagogo-Jack, S. E. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa164 · Cited by 15
Shi, H., Xiang, S., Huang, X., Wang, L., Hua, F., & Jiang, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-6890 · Cited by 15
Han, E., Kim, M. K., Jang, B. K., & Kim, H. S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0118 · Cited by 16
Yang, Y., Xu, P., Liu, Y., Chen, X., Yi-yang, H. E., & Feng, J. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/1479164121992524 · Cited by 16
Bello‐Chavolla, O. Y., Vargas‐Vázquez, A., Antonio‐Villa, N. E., Razo-Olvera, F. M. D., Elías-López, D., & Aguilar-Salinas, C. A. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s266568 · Cited by 16
Momordica Charantia: A Review of Its Effects on Metabolic Diseases and Mechanisms of Action
Cortez-Navarrete, M., Villar, M. M.-D., Ramos-González, E. J., & Pérez-Rubio, K. G. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0206 · Cited by 15
“17 Several mechanisms related to the beneficial effects of MC on insulin secretion and insulin sensitivity have been described.”
Paurobally, N., Kruger, E., & Tennant, M. (2021) · International Dental Journal · doi:10.1016/j.identj.2021.03.002 · Cited by 19
German, C., Sinsheimer, J. S., Zhou, J. J., & Zhou, H. (2021) · Biometrics · doi:10.1111/biom.13506 · Cited by 17
“Although average glycemic levels, for example, glycated hemoglobin (HbA1c), was considered the gold standard for assessing overall glycemic control (ADA, 2020), glycemic variability may be an even more meaningful measure in diabetes care (DeVries, 2013).”
BackgroundDPARD: rationale, design and initial results from the Dutch national diabetes registry
Bak, J. C. G., Mul, D., Serné, E. H., de Valk, H. W., Sas, T., Geelhoed-Duijvestijn, P. H. L. M., Kramer, M. H. H., Nieuwdorp, M., & Verheugt, C. L. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00782-x · Cited by 15
“Diabetes mellitus is diagnosed according to American Diabetes Association (ADA) and International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines [23, 24].”
BackgroundA Glimpse at the Size of the Fetal Liver—Is It Connected with the Evolution of Gestational Diabetes?
Cozma, M.-A., Găman, M., Dobrică, E.-C., Boroghină, S. C., Iancu, M. A., Creţoiu, S. M., & SIMIONESCU, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157866 · Cited by 17
Ismail, H. M., Algrafi, A. S., Amoudi, O., Ahmed, S., Althagfan, S. S., Shora, H., Aljohani, M. R., Almutairi, M. A., Alharbi, F., Alhejaili, A. L., et al. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s312376 · Cited by 15
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study
Baratta, F., Ferro, D., Pastori, D., Colantoni, A., Cocomello, N., Coronati, M., Angelico, F., & Ben, M. D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18178993 · Cited by 15
Wu, Q., Liao, C., He, M., Li, C., Zou, F., Hu, L., Wei, Y., & Zhang, W. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13521 · Cited by 15
Aittola, K., Karhunen, L. J., Männikkö, R., Järvelä‐Reijonen, E., Mikkonen, S. J., Absetz, P., Kolehmainen, M., Schwab, U., Harjumaa, M., Lindström, J., et al. (2021) · Nutrients · doi:10.3390/nu13114030 · Cited by 19
Alhakak, A., Butt, J. H., Gerds, T. A., Fosbøl, E. L., Mogensen, U. M., Krøll, J., Pallisgaard, J. L., Gislason, G., Torp-Pedersen, C. T., Køber, L., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14604 · Cited by 15
Vargas-Rodríguez, J. R., Veloz, I. G., Flores‐Morales, V., Badillo-Almaraz, J. I., Rocha-Pizaña, M. D. R., Valdés-Aguayo, J. J., & Martínez‐Fierro, M. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.758414 · Cited by 17
Ciardullo, S., Pizzi, M., Pizzi, P., Oltolini, A., Muraca, E., & Perseghin, G. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05885-x · Cited by 18
Duan, M.-J., Dekker, L. H., Carrero, J. J., & Navis, G. J. (2022) · Prevention Science · doi:10.1007/s11121-022-01357-5 · Cited by 16
Structural imaging findings are related to clinical complications in chronic pancreatitis
Nordaas, I. K., Tjora, E., Dimcevski, G. G., Haldorsen, I. S., Olesen, S. S., Drewes, A. M., Žvinienė, K., Barauskas, G., Bayram, B. K., Nørregaard, P., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12228 · Cited by 15
Perugini, J., Mercurio, E. D., Giuliani, A., Sabbatinelli, J., Bonfigli, A. R., Tortato, E., Severi, I., Cinti, S., Olivieri, F., le Roux, C. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11942-x · Cited by 17
Wang, Q., Zhu, M., Li, H., Chen, P., Wang, M., Gu, L., Zhang, X., & Chen, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s361187 · Cited by 16
Gestational diabetes mellitus, epigenetic age and offspring metabolism
Kim, C., Harrall, K. K., Glueck, D. H., Needham, B. L., & Dabelea, D. (2022) · Diabetic Medicine · doi:10.1111/dme.14925 · Cited by 16
Yu, Y., Kim, H., Song, J., Kang, J., Lee, H., Park, H. R., & Kim, Y. H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1061125 · Cited by 16
“Subjects with DM (type 2) were diagnosed with HbA1c ≥ 6.5%, fasting plasma glucose test ≥ 7.0 mM/L, or oral glucose tolerance test ≥ 11.1 mM/L (Anonymous, 2020).”
MethodInfluentialCirculating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances
Nedeva, I., Assyov, Y. S., Karamfilova, V., Vodenicharov, V., Gerganova, A., Hristova, J., & Kamenov, Z. A. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2033-6109 · Cited by 15
Dehghanbanadaki, H., Asili, P., Ghadery, A. H., Mirahmad, M., Dehnavi, A. Z., Parsaei, A., Baradaran, H. R., Azami, M., da Silva, G. J. J., Parvan, R., et al. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01476-0 · Cited by 16
Gao, Y., Sui, C., Chen, B., Xin, H., Che, Y., Zhang, X., Wang, N., Wang, Y., & Liang, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1202374 · Cited by 15
Remnant cholesterol and severity of nonalcoholic fatty liver disease
Huang, H., Wang, J., Wu, L. M., Ruan, J., Hou, L., Shen, C., & Xu, C. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01220-9 · Cited by 16
“The definition of diabetes was fasting plasma glucose ≥ 7 mmol/L, glycated hemoglobin A1c ≥ 6.5% or taking hypoglycemic medications [27].”
BackgroundInfluentialLorenzon, A. R., Moreli, J. B., Melo, R. D. M., Namba, F. Y., Staff, A. C., Yung, H. W., Burton, G. J., & Bevilacqua, E. M. A. F. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200606222123 · Cited by 16
Hotta, N., Hori, A., Okamura, Y., Baba, R., Watanabe, H., Sugawara, J., Vongpatanasin, W., Wang, J., Kim, H., Ishizawa, R., et al. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00247.2020 · Cited by 16
Eid, W., Sapp, E. H., McCreless, T., Nolan, J. R., & Flerlage, E. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.07.008 · Cited by 16
Goyal, A., Gupta, Y., Kubihal, S., Kalaivani, M., Bhatla, N., & Tandon, N. (2021) · Advances in Therapy · doi:10.1007/s12325-020-01618-1 · Cited by 16
miRNAs as biomarkers for diagnosis of type 2 diabetes: A systematic review
González‐Sánchez, L. E., Ortega‐Camarillo, C., Contreras‐Ramos, A., & Barajas-Nava, L. A. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13166 · Cited by 16
Wu, H., Li, L., Zhang, H., Tang, J., Zhang, M., Tang, H., Yue, G., Zhou, Z., & Zhou, H. (2021) · Endocrine · doi:10.1007/s12020-021-02682-5 · Cited by 15
Kanimozhi, N., & Singaravel, G. (2021) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-021-02333-x · Cited by 16
Disturbed Interhemispheric Functional and Structural Connectivity in Type 2 Diabetes
Cui, Y., Tang, T., Lu, C., Lu, T., Wang, Y., Teng, G., & Ju, S. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27813 · Cited by 15
Sanctis, V. D., Soliman, A. T., Tzoulis, P., Daar, S., Maio, S. D., Fiscina, B., & KATTAMIS, C. A. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.051 · Cited by 15
Sabella, F. M., de Feiria, S. N. B., Ribeiro, A. A., Theodoro, L. H., Höfling, J. F., Parisotto, T. M., & Duque, C. (2021) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2021.718441 · Cited by 20
Home-Based Physical Activity in Patients With Type 2 Diabetes Mellitus: A Scoping Review
Mustapa, A., Justine, M., Latir, A., & Manaf, H. (2021) · Annals of Rehabilitation Medicine · doi:10.5535/arm.21102 · Cited by 18
Extracellular Vesicles—New Players in Cell-to-Cell Communication in Gestational Diabetes Mellitus
Palma, C., McIntyre, D. H., & Salomón, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020462 · Cited by 15
Sathish, T., Tapp, R. J., & Shaw, J. E. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14529 · Cited by 15
Ren, Q., Zhang, P., Pang, W., Ma, Y., Gong, S., Ba, T., Liu, W., Zhang, F., Zhang, X., Zhang, R., et al. (2023) · Diabetes · doi:10.2337/db22-0566 · Cited by 14
Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring
Silva, L. D. P., Rego, F. G. D. M., Picheth, G., Müller‐Santos, M., & Alberton, D. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00788-1 · Cited by 14
Ndevahoma, F., Nkambule, B. B., Dludla, P. V., Mukesi, M., Natanael, K. N., & Nyambuya, T. M. (2021) · eJHaem · doi:10.1002/jha2.257 · Cited by 14
LaBarre, J. L., Hirschfeld, E., Soni, T., Kachman, M. T., Wigginton, J. E., Duren, W. L., Fleischman, J. Y., Karnovsky, A., Burant, C., & Lee, J. M. (2021) · Nutrients · doi:10.3390/nu13103365 · Cited by 17
Tomiyama, H., Imai, T., Shiina, K., Higashi, Y., Nakano, H., Takahashi, T., Fujii, M., Matsumoto, C., Yamashina, A., & Chikamori, T. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21481 · Cited by 16
Huang, X., Li, Y., Tong, X., Wu, Y., Zhang, R., Sheng, L., Xu, J., Yu, Z., Chen, Z., Sun, T., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad531 · Cited by 19
Feng, M., & Zhou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55504-9 · Cited by 16
Gao, J., Song, X., Ou, H., Cheng, X., Zhang, L.-S., Liu, C., Dong, Y., & Wang, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1388074 · Cited by 16
“The inclusion criteria for cases were based on the diagnostic standards for diabetes care set forth by the American Diabetes Association (ADA) (9).”
MethodHuang, N., Lu, B., Zhu, Z.-Z., Zhu, X., Chen, S., Shu, Z.-Y., Liu, G.-F., Peng, Y., & Li, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s477836 · Cited by 16
“16 T2DM patients with following conditions were excluded: systemic autoimmune disease, urinary tract infection, and cancer.”
BackgroundChocolate intake and risk of type 2 diabetes: prospective cohort studies
Liu, B., Zong, G., Zhu, L., Hu, Y., Manson, J. E., Wang, Μ., Rimm, E. B., Hu, F. B., & Sun, Q. (2024) · BMJ · doi:10.1136/bmj-2023-078386 · Cited by 17
The role of multimodality imaging in diabetic cardiomyopathy: a brief review
Adel, F., & Chen, H. H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1405031 · Cited by 16
“Exogenous insulin therapy, which is utilized by all DM1 patients and 1/3 rd of DM2 with heart failure patients (42), has been shown to be a risk factor for incident heart failure (43).”
Prevalence and Risk Factors of Gestational Diabetes Mellitus in Romania: Maternal and Fetal Outcomes
Iman, A. E. H., Huniadi, A. C., Şandor, M. I., Zaha, I. A., Rotar, I. C., & Iuhas, C. I. (2025) · Medicina · doi:10.3390/medicina61020194 · Cited by 17
“Socio-economic inequalities, healthcare accessibility challenges, and lifestyle differences likely play pivotal roles in shaping GDM prevalence and outcomes in this region [9–11].”
Farkas, G. J., Caldera, L. J., Hodgkiss, D. D., Mitchell, J., Pelaez, T. F., Cusnier, M. A., Cole, A. J., Daniel, S. G., Farrow, M. T., Gee, C. M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092872 · Cited by 16
“…was defined as fasting blood glucose > 100 mg/dL [11], hemoglobin A1c (HbA1c) in the range of 5.7–6.4% (prediabetic) or ≥ 6.5% (type 2 diabetes mellitus), or an oral glucose tolerance test (OGTT) result ranging between 140 and 199 mg/dL (prediabetes) or >200 mg/dL (type 2 diabetes mellitus) [81].”
InfluentialItch in Children with Type 1 Diabetes: A Cross-Sectional Study
Stefaniak, A. A., Zubkiewicz‐Kucharska, A., Matusiak, Ł., Noczyńska, A., & Szepietowski, J. C. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00403-w · Cited by 14
Illuminating Racial Inequity in Diabetes Control: Differences Based on Gender and Geography
Senteio, C. R., & Akıncıgil, A. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00830-7 · Cited by 14
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study
Caserza, L., Casula, M., Elia, E., Bonaventura, A., Liberale, L., Bertolotto, M. B., Artom, N., Minetti, S., Contini, P., Verzola, D., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13403 · Cited by 14
Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes
Carrasco-Zanini, J., Pietzner, M., & Langenberg, C. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01340-w · Cited by 15
Tang, M. L., Zhou, Y., Song, A. Q., Wang, J., Wan, Y. P., & Xu, R. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5581349 · Cited by 22
“DM was confirmed if either FBG ≥ 7:0mmol/L or HbA1c ≥ 6:5% [17].”
Lin, L., Dong, G., Tang, N., Chen, Y., & Cai, L. (2021) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2021.113721 · Cited by 15
Calapod, O., Marin, A. M., Onisâi, M., Tribus, L. C., Pop, C. S., & Fierbinteanu-Braticevici, C. G. (2021) · Medicina · doi:10.3390/medicina57050434 · Cited by 15
Lee, D., Kwak, S., Park, H. S., Ku, E. J., Jeon, H. J., & Oh, T. K. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002217 · Cited by 14
Kim, S., Song, Y. S., Kim, S., Cho, Y., & Kim, K. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0023 · Cited by 14
Systematic review with meta-analysis: autoimmune hepatitis in pregnancy
Jamaly, H. E., Eslick, G. D., & Weltman, M. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1953127 · Cited by 14
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-16
- Volume
- 43
- Issue
- Supplement_1
- Pages
- S14-S31
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4235479662
- Cited by
- 3,187
- References
- 159
- Citations by year
- 2026: 158 · 2025: 302 · 2024: 424 · 2023: 459 · 2022: 705 · 2021: 757 · 2020: 380 · 2019: 1
- FWCI
- 373.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes classification, diabetes diagnosis, diabetes diagnosis criteria, diabetes subtypes, clinical guidelines, quality of care evaluation
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, United States, History, 21st Century, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.